CDTX - Cidara Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CDTX is currently covered by 4 analysts with an average price target of $45.8. This is a potential upside of $33.99 (287.81%) from yesterday's end of day stock price of $11.81.

Cidara Therapeutics's activity chart (see below) currently has 10 price targets and 25 ratings on display. The stock rating distribution of CDTX is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 16.67% with an average time for these price targets to be met of 21.2 days.

Highest price target for CDTX is $25, Lowest price target is $25, average price target is $45.8.

Most recent stock forecast was given by LOUISE CHEN from CANTOR FITZGERALD on 20-Jun-2024. First documented stock forecast 11-May-2015.

Currently out of the existing stock ratings of CDTX, 14 are a BUY (100%).

Analyst name


Current price target

Potential Upside

Previous price target


Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score



$13.19 (111.69%)


2 months 5 days ago

0/6 (0%)

$13 (108.33%)



3 months 13 days ago

0/2 (0%)

$92.8 (341.18%)


2 years 3 months 8 days ago

1/1 (100%)

$-2.15 (-14.19%)




2 years 3 months 8 days ago

0/3 (0%)

$6.41 (284.34%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CDTX (Cidara Therapeutics) average time for price targets to be met?

On average it took 21.2 days on average for the stock forecasts to be realized with a an average price target met ratio 16.67

Which analyst has the current highest performing score on CDTX (Cidara Therapeutics) with a proven track record?


Which analyst has the most public recommendations on CDTX (Cidara Therapeutics)?

Robert Driscoll works at WEDBUSH and has 13 price targets and 8 ratings on CDTX

Which analyst is the currently most bullish on CDTX (Cidara Therapeutics)?

Robert Driscoll with highest potential upside - $88.19

Which analyst is the currently most reserved on CDTX (Cidara Therapeutics)?

David Nierengarten with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?